Cargando…
Overexpression of ICAT Inhibits the Progression of Colorectal Cancer by Binding with β-Catenin in the Cytoplasm
Inhibitor of β-catenin and T-cell factor (ICAT) was first found as a polypeptide that blocks β-catenin–TCF interaction. Abundant evidence has shown that ICAT has different functions in diverse cancers’ progression. Nevertheless, the roles it plays in colorectal cancer (CRC) have not been described....
Autores principales: | Hu, Jiancong, Wang, Zihan, Chen, Junxiong, Yu, Zhaoliang, Zhang, Jingdan, Li, Weiqian, Lin, Mengmeng, Yang, Xiangling, Liu, Huanliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485569/ https://www.ncbi.nlm.nih.gov/pubmed/34569368 http://dx.doi.org/10.1177/15330338211041253 |
Ejemplares similares
-
ICAT promotes colorectal cancer metastasis via binding to JUP and activating the NF‐κB signaling pathway
por: Wang, Zihan, et al.
Publicado: (2022) -
Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients
por: Zhang, Jingdan, et al.
Publicado: (2020) -
Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
por: Jiang, Yayun, et al.
Publicado: (2017) -
Opposing roles of ICAT and Wnt/β-catenin signaling in NSC67657-induced monocytic differentiation
por: Wang, Weijia, et al.
Publicado: (2017) -
Altered B cell immunoglobulin signature exhibits potential diagnostic values in human colorectal cancer
por: Liu, Rui-Xian, et al.
Publicado: (2023)